Hereditary Angioedema Market Size And Share

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Dimensioni, segmenti e analisi del mercato dell'angioedema ereditario entro il 2025-2031

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Scope and Analysis Hereditary Angioedema Market Size and Share

Hereditary Angioedema Market Report Analysis

Hereditary Angioedema Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BIOCRYST PHARMACEUTICALS, INC
  • CSL
  • Ionis Pharmaceuticals, Inc.
  • Merck Sharp & Dohme Corp
  • Pharming Group N. V.
  • Sanofi N. V.
  • Shire plc.
  • Teva Pharmaceutical Industries, Ltd.
  • Attune Pharmaceuticals

Regional Overview

  • Nord America
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
  • Medio Oriente e Africa

Market Segmentation

By Farmaci
  • inibitore della C1 esterasi
  • inibitore della callicreina
  • recettore della bradichinina
  • androgeni attenuati
  • altri
By Via di somministrazione
  • sottocutanea
  • endovenosa
  • orale
By Canale distributivo
  • Farmacie ospedaliere
  • Farmacie al dettaglio
  • E-Commerce
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale